Wednesday, December 1, 2021

Latest:

World AIDS Day: Ending the Stigma
New evidence supports a cancer-promoting role for enzyme MAPK6
Making safe maternal healthcare a possibility in The Gambia
COPD: what you need to know
Research staff 101: Fostering curiosity, creativity, and community

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

US FDA

Policywise

Direct-to-consumer BRCA testing: Can a reasonable decision still require caution?

March 21, 2018March 21, 2018 Clarice 0 Comments 23andMe, BRCA, genetic testing, health policy, Mary Anderlik Majumder, US FDA

On March 6, the U.S. Food and Drug Administration (FDA) authorized 23andMe to expand its direct-to-consumer (DTC) genetic test to include selected variants in BRCA1

From the Labs features a visualization of a novel approach to study gene function in the fruit fly. Image courtesy of the study authors/Cell Reports, 2021.